Application 209637
- Type
- NDA
- Sponsor
- NOVO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OZEMPIC | SEMAGLUTIDE | SOLUTION;SUBCUTANEOUS | 2MG/1.5ML (1.34MG/ML) | Yes | Yes |
| 002 | OZEMPIC | SEMAGLUTIDE | SOLUTION;SUBCUTANEOUS | 4MG/3ML (1.34MG/ML) | Yes | Yes |
| 003 | OZEMPIC | SEMAGLUTIDE | SOLUTION;SUBCUTANEOUS | 8MG/3ML (2.68MG/ML) | Yes | Yes |
| 004 | OZEMPIC | SEMAGLUTIDE | SOLUTION;SUBCUTANEOUS | 2MG/3ML (0.68MG/ML) | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209637-001 | OZEMPIC | SEMAGLUTIDE | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | |
| N209637-002 | OZEMPIC | SEMAGLUTIDE | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | |
| N209637-003 | OZEMPIC | SEMAGLUTIDE | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | |
| N209637-004 | OZEMPIC | SEMAGLUTIDE | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | |
| N209637-005 | OZEMPIC | SEMAGLUTIDE | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N209637-006 | OZEMPIC | SEMAGLUTIDE | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N209637-007 | OZEMPIC | SEMAGLUTIDE | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N209637-001 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2019-08-08 | |
| N209637-001 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2019-09-13 | |
| N209637-001 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | |
| N209637-001 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | |
| N209637-001 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2017-12-20 |
| N209637-001 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2019-04-04 | |
| N209637-001 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | |
| N209637-001 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2017-12-20 |
| N209637-001 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 10335462 | 2033-06-21 | U-2580 | 2019-07-25 | |
| N209637-002 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2020-09-24 |
| N209637-002 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | |
| N209637-002 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2020-09-24 |
| N209637-002 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 10335462 | 2033-06-21 | U-2580 | 2020-09-24 | |
| N209637-002 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-002 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | |
| N209637-003 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8536122 | 2026-03-20 | U-3355 | Drug substance, Drug product | 2022-04-29 |
| N209637-003 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2022-04-29 |
| N209637-003 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-003 | 12295988 | 2038-10-10 | U-2628 | 2025-05-29 | |
| N209637-004 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8536122 | 2026-03-20 | U-3469 | Drug substance, Drug product | 2022-11-14 |
| N209637-004 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8129343 | 2031-12-05 | U-3469 | Drug substance, Drug product | 2022-11-14 |
| N209637-004 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 10335462 | 2033-06-21 | U-2580 | Drug product | 2022-11-14 |
| N209637-004 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-004 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | |
| N209637-005 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2026-06-23 |
| N209637-005 | 12569543 | 2037-04-28 | U-4446 | 2026-06-23 | |
| N209637-005 | 10888605 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11752198 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 12214017 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11318191 | 2041-02-17 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11318191 | 2041-02-17 | U-4561 | Drug product | 2026-06-23 |
| N209637-006 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2026-06-23 |
| N209637-006 | 12569543 | 2037-04-28 | U-4446 | 2026-06-23 | |
| N209637-006 | 10888605 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-006 | 11752198 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N209637-001 | I-961 | 2028-01-28 |
| N209637-002 | I-961 | 2028-01-28 |
| N209637-003 | I-961 | 2028-01-28 |
| N209637-004 | I-961 | 2028-01-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-005 | OZEMPIC | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-006 | OZEMPIC | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-007 | OZEMPIC | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-005 | OZEMPIC | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-006 | OZEMPIC | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-007 | OZEMPIC | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 2680178bc6a6… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2019-08-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2019-09-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2017-12-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2017-12-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2019-04-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2017-12-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2017-12-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2017-12-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2017-12-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2017-12-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-001 | 10335462 | 2033-06-21 | U-2580 | 2019-07-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2020-09-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2020-09-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2020-12-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 10335462 | 2033-06-21 | U-2580 | 2020-09-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-002 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-003 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-003 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-003 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-003 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-003 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N209637-003 | 8536122 | 2026-03-20 | U-3355 | Drug substance, Drug product | 2022-04-29 | 84e616aacf4f… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-002 | I-822 | 2023-01-16 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-003 | NCE | 2022-12-05 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-003 | D-185 | 2025-03-28 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N209637-001 | NCE | 2022-12-05 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N209637-001 | I-822 | 2023-01-16 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N209637-002 | NCE | 2022-12-05 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N209637-002 | I-822 | 2023-01-16 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N209637-001 | NCE | 2022-12-05 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N209637-001 | I-822 | 2023-01-16 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N209637-002 | NCE | 2022-12-05 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N209637-002 | I-822 | 2023-01-16 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N209637-001 | NCE | 2022-12-05 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N209637-001 | NCE | 2022-12-05 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N209637-001 | I-822 | 2023-01-16 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N209637-002 | NCE | 2022-12-05 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N209637-002 | I-822 | 2023-01-16 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N209637-001 | NCE | 2022-12-05 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N209637-001 | I-822 | 2023-01-16 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N209637-002 | NCE | 2022-12-05 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N209637-002 | I-822 | 2023-01-16 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209637-001 | NCE | 2022-12-05 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209637-001 | I-822 | 2023-01-16 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209637-002 | NCE | 2022-12-05 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N209637-002 | I-822 | 2023-01-16 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N209637-001 | NCE | 2022-12-05 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N209637-001 | I-822 | 2023-01-16 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N209637-002 | NCE | 2022-12-05 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N209637-002 | I-822 | 2023-01-16 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N209637-001 | NCE | 2022-12-05 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N209637-001 | I-822 | 2023-01-16 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N209637-002 | NCE | 2022-12-05 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N209637-002 | I-822 | 2023-01-16 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N209637-001 | NCE | 2022-12-05 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N209637-001 | I-822 | 2023-01-16 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N209637-002 | I-822 | 2023-01-16 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N209637-001 | NCE | 2022-12-05 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N209637-001 | NCE | 2022-12-05 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N209637-001 | NCE | 2022-12-05 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N209637-003 | D-185 | 2025-03-28 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N209637-003 | D-185 | 2025-03-28 | 1c564ffb4f44… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ozempic | SEMAGLUTIDE | A-S Medication Solutions | 42bdd912-2393-44c4-b7e0-47672ca28991 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 |
| Ozempic | SEMAGLUTIDE | A-S Medication Solutions | 979e4df4-0597-48ea-b51c-0f699fa6d166 | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 50090-5949 |
| OZEMPIC | SEMAGLUTIDE | A-S Medication Solutions | e6da837c-0da0-41d6-973c-5559bf764367 | 2023-11-17 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 50090-6051 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0169-4130 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4130 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4130 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4130 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4130 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4130 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4130 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4132 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4136 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4181 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4772 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4772 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 0169-4772 | Ozempic | semaglutide | Novo Nordisk | NDA | Current |
| 50090-5138 | Ozempic | semaglutide | A-S Medication Solutions | NDA | Current |
| 50090-5139 | Ozempic | semaglutide | A-S Medication Solutions | NDA | Current |
| 50090-5949 | Ozempic | semaglutide | A-S Medication Solutions | NDA | Current |
| 50090-6051 | OZEMPIC | semaglutide | A-S Medication Solutions | NDA | Current |
| 50090-6051 | OZEMPIC | semaglutide | A-S Medication Solutions | NDA | Current |
| 70518-2143 | Ozempic | semaglutide | REMEDYREPACK INC. | NDA | Current |
| 70518-2143 | Ozempic | semaglutide | REMEDYREPACK INC. | NDA | Current |
| 70518-2143 | Ozempic | semaglutide | REMEDYREPACK INC. | NDA | Current |
| 70518-2143 | Ozempic | semaglutide | REMEDYREPACK INC. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85146 | SUPPL | 2026-02-24 |
| 85119 | SUPPL | 2026-02-24 |
| 85118 | SUPPL | 2026-02-24 |
| 83783 | SUPPL | 2025-10-15 |
| 83782 | SUPPL | 2025-10-15 |
| 83781 | SUPPL | 2025-10-15 |
| 83776 | SUPPL | 2025-10-15 |
| 83775 | SUPPL | 2025-10-15 |
| 81169 | SUPPL | 2025-02-07 |
| 80998 | SUPPL | 2025-02-05 |
| 80142 | SUPPL | 2024-11-05 |
| 80127 | SUPPL | 2024-11-05 |
| 75556 | SUPPL | 2023-09-25 |
| 75555 | SUPPL | 2023-09-25 |
| 75551 | SUPPL | 2023-09-25 |
| 75550 | SUPPL | 2023-09-25 |
| 72296 | SUPPL | 2022-10-11 |
| 72295 | SUPPL | 2022-10-11 |
| 72275 | SUPPL | 2022-10-07 |
| 70645 | SUPPL | 2022-03-29 |
| 70644 | SUPPL | 2022-03-29 |
| 70639 | SUPPL | 2022-03-29 |
| 67061 | SUPPL | 2021-04-14 |
| 67060 | SUPPL | 2021-04-14 |
| 67048 | SUPPL | 2021-04-13 |
| 61599 | SUPPL | 2020-01-17 |
| 61594 | SUPPL | 2020-01-17 |
| 61593 | SUPPL | 2020-01-17 |
| 61112 | SUPPL | 2019-12-02 |
| 61113 | SUPPL | 2019-11-29 |
| 61094 | SUPPL | 2019-11-29 |
| 58289 | SUPPL | 2019-04-11 |
| 58271 | SUPPL | 2019-04-10 |
| 51050 | ORIG | 2018-01-16 |
| 50623 | ORIG | 2017-12-07 |
| 50622 | ORIG | 2017-12-06 |